tbuckley/cabot-search huggingface dataset:
Toxicity of over-the-counter stimulants
Authors: P. Pentel
Journal: JAMA (1984)

Over-the-counter stimulants (phenylpropanolamine hydrochloride, ephedrine, pseudoephedrine, caffeine) are used widely as decongestants, anorectic agents, amphetamine substitutes, and "legal stimulants." Toxic effects may result from overdose, drug interactions, or diseases that increase sensitivity to sympathomimetic agents. The most important toxic effect of the a-adrenergic agonist phenylpropanolamine is hypertension, which may result in hypertensive encephalopathy or intracerebral hemorrhage. The therapeutic index of phenylpropanolamine is low, and severe hypertension may occur after ingestion of less than three times the therapeutic dose. Ephedrine and pseudoephedrine may also cause hypertension, as well as tachyarrhythmias due to β-adrenergic stimulation. Toxic reactions from caffeine are characterized by agitation, seizures, tachyarrhythmias, and hypotension. Management of toxic reactions to over-the-counter stimulants includes control of hypertension with a rapidly acting vasodilator, β-blockers for tachyarrhythmias, and control of seizures. (<i>JAMA</i>1984;252:1898-1903)
Iffy Climate Deters Medical Technology Innovation
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Inauguration '63
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Influenza Immunization
Authors: James L. Fisher
Journal: JAMA (1967)

<h3>To the Editor:—</h3> The Public Health Service predicted an influenza outbreak (<b>201</b>, July 24, 1967, adv p 37). They recommend two injections of vaccine, the first in October and the second in December. Those of us who remember the great epidemic of 1918 know that it started in the lovely weather of September and was raging by October. Active immunity from the first injection reaches a peak in six weeks, but reinforcement from the second is effective more quickly. An October start is entirely too late. I propose to vaccinate my patients first in August and finish by the end of September. Then they will be at their peak of immunity in time for it to be effective in the fall epidemic.
The Current Status of Hazardous Solid Waste Management
Authors: Hugh B. Kaufman
Journal: Environmental Health Perspectives (1978)

Growth of the population and of industrialization, and substandard disposal of the increased waste products thus generated, have resulted in numerous documented cases of harm to human, plant, and animal health. The Resource Conservation and Recovery Act (1976), its stated goals, and its intended means of implementation, are discussed relative to hazardous waste problems. Subtitle C of this Act, and the authority granted by it to the U.S. Environmental Protection Agency, are explained. Standards and regulations have been imposed upon those responsible for generating and transporting hazardous wastes, to ensure the ultimate safe disposal of such wastes in environmentally suitable, properly licensed facilities.
Strategies for reducing grade 2 and 3 adverse events due to immunotherapy in a Spanish university hospital.
Authors: Ana Gomez, Paloma Gómez Solana, Elena Ruiz, Antonio Anton, Enrique Aranda, Carlos Camps, Manuel Constenla, Juan Jesús Cruz, Eduardo Díaz-Rubio, Margarita Feyjoo, Jesús García Foncillas, Pedro Gascon, Vicente Guillem, Rafael Lopez, Ilse Lugo, Alfredo Carrato
Journal: Journal of Clinical Oncology (2019)

e18295 Background: To develop an improvement project, the Lung Cancer Unit of Ramón y Cajal Hospital (Madrid) analyzed 45 patients treated with immunotherapy in 2017 and detected that 55% presented moderate-to-severe Adverse Events (AEs). Consequently, a specialized team from Ramon y Cajal Hospital and the ECO Foundation proposed to identify improvement areas that reduce grade 2 (G2) and 3 (G3) AEs. ECO is a collaboration of experts representing the major Spanish hospitals in the pursuit of excellence in cancer treatment. Methods: The team used as an instrument the American Society of Clinical Oncology (ASCO) Quality Training Program (QTP). A data collection process was conducted before attending the first out of three sessions of the QTP with the revision of medical records from lung cancer patients. The goal for the final QTP session in June 2018 was to reduce G2 and G3 AEs by 25%, by standardizing patient education sessions using ASCO guidelines for the management of immune-related AEs. Results: The data collected showed that G2 and G3 AEs had an impact on quality of care, specifically a treatment delay in 31% of patients, unscheduled visits in 19%, serious complications in 11% and patient dissatisfaction with the reporting system. The team created a cause and effect diagram, in which the most relevant causes were inadequate patient knowledge and a lack of communication with patients between visits. A run chart of the percentage of G2 and G3 AEs during 2017 displayed that G2 AEs were higher during January and August; and G3 AEs in February and December. The team, including patient advocates, prioritized the implementation of these short-term measures for patients: improvement of education, education follow-up, satisfaction questionnaire development and AE knowledge test. By June 2018, the resulting value of the “(mean + range)/standard deviation” formula for AEs perceived knowledge in patients increased from 5.4 to 11.1 points, the same value for patients’ AEs knowledge increased from 7.3 to 13.8 points, the percentage of G2 AEs reduced in 5% and the percentage of G3 AEs maintained in 0%. Conclusions: This improvement approach indicates the need to continue further quality projects in healthcare. Broader participation of Spanish hospitals in improvement initiatives will enhance the goal of a quality-oriented health care system.
Abstract 2474: Automated somatic variant classifier to reduce false positives identified by tumor normal variant callers
Authors: Alena S. Harley, Corine K. Lau, Eve Shinbrot
Journal: Cancer Research (2019)

Abstract Accurate identification of somatic mutations is key to targeted cancer therapies. However, due to the complexity of next-generation sequencing, there are many variables that give rise to sequencing and alignment artifacts. Most sequencing workflows using tumor normal paired samples rely on the intersection or union of mutations by more than one somatic variant caller such as Mutect2, Strelka, VarScan2, Muse, and SomaticSniper. Yet, they still contain a number of false positive and false negative calls. Therefore, there is a need for a manual review of variants using Integrative Genomics Viewer (IGV) to incorporate information that is difficult to take into account in automated workflows. To alleviate the burden of manual inspection, we present an automated classification method to pre classify detected somatic variants into true or false classes for further manual review. Methods: We created a false positive classifier that utilizes automated IGV visualization of somatic variants. Our somatic workflow involves tumor normal DNA sequencing, BWAMEM alignment, deduplication of reads via Picard, somatic calling using two somatic callers, followed by the union of the detected variants, SnpEff annotation, and extracting nonsilent variants with variant allele fractions greater than 5 percent. We used the data for 1,413 nonsilent variants from a set of 10 tumor normal pairs of various cancer types. The variants were scored by cancer analysts using IGV. Initial false positive rate was 28 percent. We fine tuned Residual Deep Neural Network which utilizes weights from the network with the same architecture trained on ImageNet. Discriminative fine tuning was performed in two stages: first unfreezing the last fully connected layer only, and then unfreezing all the layers and training with differential learning rates. Results and Conclusion: Our method achieves 93 percent overall accuracy. The classifier greatly reduces the false positive rate for the set of variant calls from 28 percent down to 4 percent at the expense of calling 3 percent of true variants false. Previously, deep neural networks have been shown to yield the state of the art performance in multiple domains including image processing, speech, and text processing. In this work, we describe a way to fine tune Residual Neural Network trained on a large image data set to perform false positive variant detection in tumor-normal variant alignment snapshots from IGV. Our general approach that significantly reduces false positive rate of putative variants can be extended to any subset of somatic callers. Citation Format: Alena S. Harley, Corine K. Lau, Eve Shinbrot. Automated somatic variant classifier to reduce false positives identified by tumor normal variant callers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2474.
Incorrect Value.
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The status of women at one academic medical center. Breaking through the glass ceiling
Authors: K. G. Nickerson
Journal: JAMA (1990)

Despite recent gains in admission to medical school and in obtaining junior faculty positions, women remain underrepresented at senior academic ranks and in leadership positions in medicine. This discrepancy has been interpreted as evidence of a "glass ceiling" that prevents all but a few exceptional women from gaining access to leadership positions. We analyzed data from Columbia University College of Physicians &amp; Surgeons, New York, NY, for all faculty hired from 1969 through 1988 and found that the likelihood of promotion on the tenure track was 0.40 for women and 0.48 for men (ratio, 0.82; 95% confidence interval, 0.56 to 1.20); on the clinical track the likelihood of promotion was 0.75 for women and 0.72 for men (ratio, 1.04; 95% confidence interval, 0.56 to 1.94). Additional analysis of current faculty showed that in the academic year 1988-1989 the proportion of women at each tenure track rank at the College of Physicians &amp; Surgeons equaled or exceeded the national proportion of women graduating from medical school, once allowance was made for the average time lag necessary to attain each rank. On the clinical track women were somewhat overrepresented, particularly at the junior rank. National data that describe medical school faculty, which combine tenure and clinical tracks, showed that in 1988 women were proportionately represented at each rank once the lead time from graduation was considered. We conclude that objective evidence shows that women can succeed and are succeeding in gaining promotions in academic medicine. (<i>JAMA</i>. 1990;264:1813-1817)
PROFESSORS.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE MEDICAL SIDE OF THE DEPARTMENT OF AGRICULTURE.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Poetry
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
FORMIC ACID IN THE BODY
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reimbursing physicians and hospitals
Authors: T. Bodenheimer
Journal: JAMA (1994)

The first article in this series described the different modes of financing health care—out-of-pocket payments, individual health insurance, employment-based health insurance, and government financing. Each of these payment mechanisms attempted to solve the problem of unaffordable care for certain groups in the population, but each in turn created new problems by stimulating rapid rises in health care costs. The method of reimbursement of physicians and hospitals contributed to health care inflation; thus, a change in how health care providers are paid is currently being promoted as a solution to the cost problem. Dr Mary Young recently finished her family practice residency and joined a small group practice, PrimaryCare. On her first day, her first patient was insured by Blue Shield; PrimaryCare was paid a fee for the physical examination and for the electrocardiogram (ECG) performed. Dr Young's second patient required the same services, for which PrimaryCare received no payment but
Hepatic Pyemia
Authors: Ludwig J. Pyrtek, Stanley A. Bartus
Journal: New England Journal of Medicine (1965)

HEPATIC pyemia signifies invasion of the liver by pyogenic organisms, resulting in the formation of single or multiple liver abscesses. The widespread use of antibiotics has not eliminated this serious complication of sepsis. The ability to scan the liver has facilitated the diagnosis of space-occupying lesions. As yet, this modality is not universally available. In any event, the diagnosis of hepatic pyemia is primarily a clinical one, but it remains elusive, resulting in a mortality that is inordinately high. A critical review of pyogenic liver abscess evaluating diagnosis and treatment in the antibiotic era is presented.MaterialBetween 1942 and . . .
Impact of the device based shape change on left ventricular diastolic function in a pacing induced cardiomyopathy model Tomotsugu Tabata, Kiyotaka Fukamachi, Masami Takagaki, Lisa A. Cardon, Yoshie Ochiai, Kazuyoshi Doi, Patric M. McCarthy, Cyril J. Schweich, Jr., Todd J. Mortier, Richard F. Schroeder, James D. Thomas. The Cleveland Clinic Foundation, Cleveland, OH, Myocor Inc., Plymouth, MN
Journal: Journal of the American College of Cardiology (2001)
Gaseous Pollutants in Particulate Matter Epidemiology: Confounders or Surrogates?
Authors: Jeremy A. Sarnat, Joel Schwartz, Paul J. Catalano, Helen H. Suh
Journal: Environmental Health Perspectives (2001)

Air pollution epidemiologic studies use ambient pollutant concentrations as surrogates of personal exposure. Strong correlations among numerous ambient pollutant concentrations, however, have made it difficult to determine the relative contribution of each pollutant to a given health outcome and have led to criticism that health effect estimates for particulate matter may be biased due to confounding. In the current study we used data collected from a multipollutant exposure study conducted in Baltimore, Maryland, during both the summer and winter to address the potential for confounding further. Twenty-four-hour personal exposures and corresponding ambient concentrations to fine particulate matter (PM(2.5)), ozone, nitrogen dioxide, sulfur dioxide, and carbon monoxide were measured for 56 subjects. Results from correlation and regression analyses showed that personal PM(2.5) and gaseous air pollutant exposures were generally not correlated, as only 9 of the 178 individual-specific pairwise correlations were significant. Similarly, ambient concentrations were not associated with their corresponding personal exposures for any of the pollutants, except for PM(2.5), which had significant associations during both seasons (p < 0.0001). Ambient gaseous concentrations were, however, strongly associated with personal PM(2.5) exposures. The strongest associations were shown between ambient O(3) and personal PM(2.5) (p < 0.0001 during both seasons). These results indicate that ambient PM(2.5) concentrations are suitable surrogates for personal PM(2.5) exposures and that ambient gaseous concentrations are surrogates, as opposed to confounders, of PM(2.5). These findings suggest that the use of multiple pollutant models in epidemiologic studies of PM(2.5) may not be suitable and that health effects attributed to the ambient gases may actually be a result of exposures to PM(2.5).